PK Study to Assess Drug-drug Interaction Between Sitravatinib and a P-gp Inducer and an Inhibitor.
Status:
Recruiting
Trial end date:
2022-10-12
Target enrollment:
Participant gender:
Summary
A Phase 1 Open-label, Two-cohort, One-sequence Crossover Study to Investigate the Effect of P
glycoprotein Inhibitor (Itraconazole) and Inducer (Rifampin) on the Pharmacokinetics, Safety,
and Tolerability of Sitravatinib in Healthy Subjects.